Canada Markets close in 3 mins

SOL Global Investments Corp. (SOLCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.8000-0.0600 (-3.23%)
As of 03:23PM EST. Market open.

SOL Global Investments Corp.

100 King Street West
Suite 5600
Toronto, ON M5X 1C9

Sector(s)Financial Services
IndustryAsset Management
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew A. DeFrancescoChairman & CEO674.24kN/A1970
Mr. Peter D. Liabotis CPA, CASpecial Advisor177.41kN/A1970
Mr. Paul L. Kania CPA, CPAChief Financial OfficerN/AN/AN/A
Prof. Michael Barnes M.D.Chief Medical OfficerN/AN/AN/A
Mr. Micheal BondurantChief Strategy OfficerN/AN/A1970
Mr. Paul T. NormanChief Exec. Officer of HeavenlyRxN/AN/A1965
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


SOL Global Investments Corp. is a principal investment firm with a focus on the biopharmaceutical and cannabis industry in the United States. The company was formerly known as Scythian Biosciences Corp. and changed its name to SOL Global Investments Corp. in October 2018. SOL Global Investments Corp. is based in Toronto, Canada.

Corporate Governance

SOL Global Investments Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.